家庭脉搏血氧监测在急诊出院的COVID-19患者中的新应用:识别需住院治疗者
本研究在急诊和门诊检测中心纳入209例疑似COVID-19患者,其中77例阳性并纳入分析,每例获发家用脉搏血氧仪并每8小时记录SpO2,若持续SpO2<92%或自觉需急诊医疗则返回急诊。77例中22例(29%)后续住院;家庭静息SpO2<92%与住院可能性增加相关(相对风险=7.0,95%CI 3.4–14.5,P<0.0001),也与ICU入住、急性呼吸窘迫综合征和脓毒性休克风险增加相关。住院患者中50%仅因偶然发现低SpO2而无症状加重返院;33%未住院患者表示若无血氧仪在家安心则会返回急诊。研究表明采用SpO2 92%界值时居家脉搏血氧监测可识别初期非重症COVID-19患者的住院需求,并减少不必要的急诊复诊。
要点
- 急诊出院的初期非重症COVID-19患者居家每8小时测SpO2,持续<92%或自觉需急诊医疗时返回急诊。
- 家庭静息SpO2<92%者住院风险为SpO2≥92%者的7.0倍(95%CI 3.4–14.5,P<0.0001)。
- 住院的COVID-19患者中50%仅因偶然发现家庭低SpO2返院,而无症状加重。
- 家庭SpO2<92%也与ICU入住、急性呼吸窘迫综合征和脓毒性休克风险增加相关。
- 33%未住院患者表示若无家用脉搏血氧仪在家安心则会返回急诊。
适用人群与场景
- 急诊和门诊检测中心纳入的疑似COVID-19患者,最终77例COVID-19阳性且初期非重症者纳入分析。
诊断标准与关键阈值
- 家庭持续SpO2<92%为返回急诊的阈值;SpO2<92%与≥92%相比住院相对风险=7.0(95%CI 3.4–14.5,P<0.0001)。
处置流程与药物剂量
- 每例患者获发家用脉搏血氧仪,并被告知每8小时记录一次SpO2。
- 若家庭SpO2持续<92%或患者自觉需要急诊医疗,则返回急诊。
红旗征与不能漏的情况
- 家庭SpO2<92%与住院、ICU入住、急性呼吸窘迫综合征和脓毒性休克风险增加相关。
研究设计与关键结果
- 研究纳入209例疑似COVID-19患者,其中77例阳性并纳入分析;22/77(29%)后续住院。
- 家庭静息SpO2<92%与住院可能性增加相关(相对风险=7.0,95%CI 3.4–14.5,P<0.0001)。
- 家庭SpO2<92%也与ICU入住、急性呼吸窘迫综合征和脓毒性休克风险增加相关。
- 住院患者中50%仅因偶然发现家庭低SpO2而无症状加重返回急诊。
- 33%未住院患者表示若无脉搏血氧仪在家安心则会返回急诊。
证据类型、等级与局限
- 证据类型:研究论文(队列研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对急诊出院的初期非重症COVID-19患者,可发放家用脉搏血氧仪并嘱每8小时测SpO2,持续<92%或自觉需急诊医疗时返院。
- 家庭SpO2<92%提示住院、ICU入住、急性呼吸窘迫综合征和脓毒性休克风险增加,即使症状未加重也需评估。
- 居家SpO2监测可能减少不必要的急诊复诊。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Our objective was to evaluate patient-reported oxygen saturation (SpO2 ) using pulse oximetry as a home monitoring tool for patients with initially nonsevere COVID-19 to identify need for hospitalization.
METHODS: Patients were enrolled at the emergency department (ED) and outpatient testing centers. Each patient was given a home pulse oximeter and instructed to record their SpO2 every 8 hours. Patients were instructed to return to the ED for sustained home SpO2 < 92% or if they felt they needed emergent medical attention. Relative risk was used to assess the relation between hospitalization and home SpO2 < 92% in COVID-19-positive patients.
RESULTS: We enrolled 209 patients with suspected COVID-19, of whom 77 patients tested positive for COVID-19 and were included. Subsequent hospitalization occurred in 22 of 77 (29%) patients. Resting home SpO2 < 92% was associated with an increased likelihood of hospitalization compared to SpO2 ≥ 92% (relative risk = 7.0, 95% confidence interval = 3.4 to 14.5, p < 0.0001). Home SpO2 < 92% was also associated with increased risk of intensive care unit admission, acute respiratory distress syndrome, and septic shock. In our cohort, 50% of patients who ended up hospitalized only returned to the ED for incidental finding of low home SpO2 without worsening of symptoms. One-third (33%) of nonhospitalized patients stated that they would have returned to the ED if they did not have a pulse oximeter to reassure them at home.
CONCLUSIONS: This study found that home pulse oximetry monitoring identifies need for hospitalization in initially nonsevere COVID-19 patients when a cutoff of SpO2 92% is used. Half of patients who ended up hospitalized had SpO2 < 92% without worsening symptoms. Home SpO2 monitoring also reduces unnecessary ED revisits.
参考来源
- Shah S, Majmudar K, Stein A, et al. Novel Use of Home Pulse Oximetry Monitoring in COVID-19 Patients Discharged From the Emergency Department Identifies Need for Hospitalization. Acad Emerg Med. 2020. PMID: 32779828. doi:10.1111/acem.14053
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。